ALISO VIEJO, Calif., Oct. 17, 2007 (PRIME NEWSWIRE) -- Clarient, Inc. (Nasdaq:CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it will report its financial results for its third quarter and nine months ended September 30, 2007 after the stock market closes on Tuesday, October 30.
Date: Tuesday, October 30, 2007
Start Time: 5:00 p.m. EDT
Call-in Number: 1-877-356-3962
(International) +706-634-5888
Webcast: www.clarientinc.com/investor
Web Replay: For those unable to participate during the
live broadcast, the webcast replay will be archived at
www.clarientinc.com/investor shortly after the call and
will be available for one year.
Host: President and CEO, Ronald A. Andrews.
Format: Discussion of third quarter 2007 financial results
followed by Q&A.
About Clarient
Clarient combines innovative technologies with world class expertise to assess and characterize cancer. Clarient's mission is to provide the services, resources and critical information to improve the quality and reduce the cost of patient care as well as accelerating the drug development process. The Company's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies.
The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory providing the most advanced oncology testing and drug development services available both onsite and over the web. Clarient is a Safeguard Scientifics, Inc. partner company. For more information, visit www.clarientinc.com.
About Safeguard
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company, builds value in growth-stage technology and life sciences businesses. Safeguard provides growth capital as well as a range of strategic, operating and management resources to our partner companies. Safeguard participates in growth buyout financings, including corporate spin-outs and management buyouts, expansion financings, industry consolidations and early-stage financings. www.safeguard.com